Correlation Between Estrella Immunopharma and Precigen

Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Precigen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Precigen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Estrella Immunopharma and Precigen, you can compare the effects of market volatilities on Estrella Immunopharma and Precigen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Precigen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Precigen.

Diversification Opportunities for Estrella Immunopharma and Precigen

-0.06

Correlation Coefficient

Estrella Immunopharma  Precigen

Good diversification

The 3 months correlation between Estrella and Precigen is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Precigen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Precigen and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Precigen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Precigen has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Precigen go up and down completely randomly.

Pair Corralation between Estrella Immunopharma and Precigen

Assuming the 90 days horizon Estrella Immunopharma is expected to generate 1.22 times less return on investment than Precigen. In addition to that, Estrella Immunopharma is 2.66 times more volatile than Precigen. It trades about 0.05 of its total potential returns per unit of risk. Precigen is currently generating about 0.17 per unit of volatility. If you would invest  93.00  in Precigen on December 30, 2024 and sell it today you would earn a total of  66.00  from holding Precigen or generate 70.97% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	58.06%
Values	Daily Returns

Estrella Immunopharma  vs.  Precigen

Estrella Immunopharma

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Estrella Immunopharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Precigen

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Precigen are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, Precigen displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Estrella Immunopharma and Precigen

The main advantage of trading using opposite Estrella Immunopharma and Precigen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Precigen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will offset losses from the drop in Precigen's long position.

The idea behind Estrella Immunopharma and Precigen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..